Lung cancer care is evolving fast. Join us at #ESMO26 as we explore how to advance the non-small cell lung cancer (#NSCLC) treatment landscape — from today’s standards of care to tomorrow’s emerging modalities—to shape what comes next for patients. https://t.co/m6cOWKpzy9